Abstract
Atrial fibrillation (AF) is a significant burden for healthcare systems due to increased morbidity and mortality rates. It is a major cause of ischaemic stroke, which is considered one of the most serious and disabling complications of AF. Stroke prevention with oral anticoagulation (OAC) by vitamin K antagonists (VKA) or non-vitamin K antagonists (NOAC) is therefore a significant component of AF management. Both VKAs and NOACs are effective for the prevention of stroke in AF; however, stringent adherence to the recommended treatment regimen is crucial, both from a prescriber’s and a patient’s perspective.
Original language | English |
---|---|
Pages (from-to) | 1308-1309 |
Number of pages | 2 |
Journal | Heart |
Volume | 103 |
Issue number | 17 |
DOIs | |
Publication status | Published - Sep 2017 |
Externally published | Yes |
Keywords
- Atrial fibrillation
- Health care delivery
- Medication adherence
- Stroke